Clinical Trial Update: A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update evaluating the efficacy and safety of apremilast in Japanese pediatric participants with moderate to severe plaque psori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Plaque Psoriasis | Phase 3 | Status: ACTIVE_NOT_RECRUITING